Sorrento to Present New Data on Advanced Immunotherapies at Multiple Upcoming Scientific Conferences

NEXT STORY
Innate Pharma to share new long-term data on Lumoxiti at 2019 American Society of Hematology annual meeting
PREV STORY
ADMA Biologics Reports Third Quarter 2019 Financial Results and Highlights Recent Company Progress
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Advanced Accelerator Applications Reports 39% Sales Growth for Third Quarter 2017

$3.9 Billion All Cash Proposed Tender Offer by Novartis European Approval of Lutetium Lu ...

author_avatar
NASDAQ Market News

Helsinn and Lyfebulb Announce Partnership for Second Annual Patient-Driven Innovation Summit in Cancer

The award will be presented to the Patient Entrepreneur demonstrating outstanding science and potential ...

author_avatar
NASDAQ Market News

OncBioMune Preparing to Initiate Trials of Novel Therapeutic Ovarian Cancer Vaccine

BATON ROUGE, La., Oct. 17, 2017 (GLOBE NEWSWIRE) -- OncBioMune Pharmaceuticals, Inc. (OTCQB:OBMP) ("OncBioMune" ...

author_avatar
NASDAQ Market News